Suppr超能文献

游离脂肪酸、胰岛素、胰高血糖素及肾上腺素对人体酮体生成的影响

Effects of free fatty acids, insulin, glucagon and adrenaline on ketone body production in humans.

作者信息

Miles J M, Haymond M W, Gerich J E

出版信息

Ciba Found Symp. 1982;87:192-213. doi: 10.1002/9780470720691.ch11.

Abstract

In normal human subjects, when plasma insulin, glucagon and growth hormone were 'clamped' at basal concentrations (by infusion of somatostatin plus replacement infusion of these hormones), infusion of Intralipid and heparin increased plasma free fatty acid (FFA) concentrations to approx. 1.3 mM, and ketone body production increased 4-5 fold to approx. 11 mumol . kg -1 . min-1. Hyperglucagonaemia did not further increase ketogenesis. In conditions of combined insulin and glucagon deficiency (by infusion of somatostatin without insulin and glucagon), administration of Intralipid and heparin increased plasma FFA concentrations to approx. 2.2 mM but a further increase in ketone body production did not accompany this increase. In these conditions hyperglucagonaemia increased ketogenesis by 2-3 fold the increment seen in control studies. Infusion of adrenaline (epinephrine) in conditions in which insulin secretion was not inhibited caused only a transient increase in plasma FFA concentrations and in ketone body production. These data indicate: (1) that in humans increased FFA availability can markedly augment ketogenesis in the absence of insulin deficiency and without hyperglucagonaemia; (2) that glucagon can increase ketone body production during insulin deficiency but not in its absence; and (3) that insulin deficiency may be accompanied by increased ketogenesis only because of a lack of its restraint on lipolysis and because of the action of glucagon. Glucagon may be important in determining the magnitude of ketone body production for a given degree of FFA availability and insulin deficiency, and may be necessary for attainment of maximal rates of ketogenesis. Adrenaline increases ketone body production in humans, but whether this is primarily due to a direct effect on the liver or is mediated through enhancement of lipolysis remains to be determined.

摘要

在正常人体中,当血浆胰岛素、胰高血糖素和生长激素被“钳制”在基础浓度水平(通过输注生长抑素并补充输注这些激素)时,输注脂肪乳剂和肝素可使血浆游离脂肪酸(FFA)浓度升高至约1.3 mM,酮体生成增加4 - 5倍,达到约11 μmol·kg⁻¹·min⁻¹。高胰高血糖素血症并未进一步增加酮体生成。在胰岛素和胰高血糖素联合缺乏的情况下(通过输注生长抑素且不补充胰岛素和胰高血糖素),给予脂肪乳剂和肝素可使血浆FFA浓度升高至约2.2 mM,但酮体生成并未随此增加而进一步升高。在这些情况下,高胰高血糖素血症使酮体生成增加了2 - 3倍,高于对照研究中的增加幅度。在胰岛素分泌未受抑制的情况下输注肾上腺素,仅使血浆FFA浓度和酮体生成出现短暂升高。这些数据表明:(1)在人体中,在不存在胰岛素缺乏和高胰高血糖素血症的情况下,增加FFA的可利用性可显著增强酮体生成;(2)胰高血糖素可在胰岛素缺乏时增加酮体生成,但在不存在胰岛素缺乏时则不能;(3)胰岛素缺乏可能仅因缺乏对脂肪分解的抑制作用以及胰高血糖素的作用而伴有酮体生成增加。对于给定程度的FFA可利用性和胰岛素缺乏,胰高血糖素可能在决定酮体生成量方面很重要,并且可能是达到最大酮体生成速率所必需的。肾上腺素可增加人体的酮体生成,但这主要是由于对肝脏的直接作用还是通过增强脂肪分解介导,仍有待确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验